Arihanth Medi Pharma is acknowledged world wide at pharma horizon, providing a broad range of Pharmaceutical Products to cope with the necessity of ailing humanity. Our company aim to play major role in Supply chain of Specialty Medicines in India by adopting global distribution standards and to provide uniform, one point distribution & marketing solution in the Super Specialty Drugs segment.
Since inception, our main focus is to deliver quality products to our clients. The raw material used in the manufacturing is procured from the reliable vendors of the industries. We supply premium quality cancer treatment drugs, cancer treatment medicines, pharmaceutical drugs and more that are anti allergic and is quick in treating diseases. Further, we have an excellent state-of-the-art infrastructure to achieve superior quality products. Every manufacturing stage is minutely scanned by a team of pharmaceutical experts. We have an integrated testing quality control lab that is well equipped with adequate equipment. These tools are used to take out impurity profiles and orderly analysis of assortments.
We have embarked upon with the aim to be one of the fastest growing and leading company in our domain by providing unmatched products, incomparable services at the most competitive prices to our valued customers. We are committed towards, achieving the highest quality standards, understanding the customer's need, changing market scenario and delivering products accordingly.
Company has vision “To play major role in Supply chain of Specialty Medicines in India by adopting global distribution standards. Company has vision to provide uniform, one point distribution & marketing solution in the Super Specialty Drugs segment.”
“Company intents to increase its branch network for distribution of Super Specialty Drugs across India. With the use of latest technology, Company also intents to promote Online Pharmacy concepts in India. This will provide cost effective solutions for the Medicines from the various Companies. The combine of quality, economy & affordability will largely benefit to Anti-Cancer , HIV & Nephrology Patients.”